معرفی
Dr. Yih-Kai Chan is a Program Manager and Research Fellow at the Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne. He is part of the Behaviour, Environment and Cognition Research Program, where he leads and contributes to large-scale, multicentre clinical and health services research initiatives focusing on cardiovascular disease, diabetes, and metabolic disorders.
His research expertise lies in designing and implementing randomized controlled trials (RCTs), applied health economics, health policy, and research governance. He has played a key role in major NHMRC-funded projects and international collaborations such as the MOZART Disease Surveillance Study in Mozambique, ensuring high standards in data collection and management.
- Cardiovascular Disease
- Diabetes
- Metabolic Disease
- Health Services Research
- Applied Health Economics
- Chronic Disease Management
The selected publications reflect a strong trend in evaluating cost-effective, nurse-led, and multidisciplinary interventions for heart failure and atrial fibrillation, with a focus on improving patient outcomes and reducing healthcare utilization. His work frequently appears in top-tier medical journals such as The Lancet, Circulation, and European Heart Journal.
Scientific Awards and Recognitions:
- Post-Doctoral Fellowship from Novartis Australia (2011–2012)
- Funding and research support from Novartis Australia, Royal Flying Doctor Services Victoria, Bupa Australia, Sanofi Australia, Novo Nordisk Australia, and MBF Foundation (2012–2017)
Dr. Chan has served as a provisional HDR supervisor and has been actively involved in securing and managing major research grants, including multiple NHMRC Project, Program, and Centre of Research Excellence grants. He has collaborated extensively with leading Australian researchers across institutions and has contributed to national policy discussions through co-authoring three Federal Parliamentary Reports: The Heart of Inequality (2017), Hidden Hearts (2016), and Rediscovering Heart Failure (2015).
He is affiliated with the Mary MacKillop Institute for Health Research at ACU and previously held research positions at the Baker IDI Heart and Diabetes Institute and the University of Auckland. His work bridges clinical research, public health policy, and translational medicine, with a strong emphasis on equity and scalable interventions.
